SEC Filing 8-K: Travere Therapeutics, Inc.

September 14, 2021 5:30pm EDT

Source: SEC (Index ) via Sqoop

  • § Departure/Appointment/Compensation of Officers/Directors;
  • § Financial Statements and Exhibits;

XBRL Reports

XBRL Sources

101.SCH XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
101.LAB XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
101.PRE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT